Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use

We optimized a protocol for the combined immunomagnetic depletion of alloreactive CD25/CD71 T cells under current good manufacturing practice conditions and tested the efficacy in five donor-recipient pairs.